Five Prime raises $62.4M in IPO

Five Prime Therapeutics Inc. (NASDAQ:FPRX) rose $0.08 to $13.08 on Wednesday after raising $62.4 million through the sale of 4.8 million shares at $13 in an IPO. The $13 price valued the company at $208.2 million. Jefferies; BMO Capital Markets; Wells Fargo; and Guggenheim Securities are underwriters.

The price was the midpoint of the $12-$14 range Five Prime set earlier this month, with more shares sold than the 4 million planned. The company filed to raise up to $60 million in July. ...